Thus, starvation of cytokine, such as IL-2, may emerge as a new firearm among the arsenal of immunotherapeutic strategies, which either alone or in combination, enrich the picture of immune checkpoint inhibitors available to fight cancers. The gene discussed is IL2; the disease is cancer.